Tuesday, 18 Dec 2018

You are here

Neuropathic Like Knee Pain

Fernandez and colleagues have shed further light on a significant subset of patients with knee pain - specifically, those with neuropathic like knee pain (NKP) that includes those with knee pain modified by central and peripheral neurologic dysfunction.

They undertook a cross-sectional study of a UK (n = 9506) postal questionnaire. Questions included KP severity (numerical rating scale) identifying those with knee pain (KP).

They found that KP was common (28.2%) amongst responders, and that nearly half of these (13.65%) qualified as NKP (i.e., 3.9% of the total population). 

NKP was based on the modified painDETECT questionnaire (PDQ) and implies either central or localised damage to the nervous system or nerve fibres around that modifies the KP experience. NKP has symptoms of pain, burning pain, tingling or prickling, mechanical and thermal hyperalgesia, allodynia, paroxysmal pain and numbness.

Those with NKP were more likely to be women and have fibromyalgia (OR=4.07). widespread pain (OR 1.93), nodal osteoarthritis (OR 1.80), injury (OR 1.50), pain catastrophising (OR 5.37) and fatigue (OR 5.37) compared with non-NKP respondents.

Their data suggest that primarily central risk factors contributed to NKP (8% central vs. 3% peripheral contributions).

Identifiying NKP and central risk factors may help modify treatment strategies.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Dendrimer Nanocarrier Delivers IGF-1 to Degenerative Cartilage

Researchers from MIT have developed a novel treatment for osteoarthritis (OA) by using dendrimer-based nanocarriers to deliver insulin-like growth factor 1 (IGF-1) to chondrocytes within joint cartilage and in animal models have shown when these nanocarriers injected into rat knees in models of OA, they reduced cartilage degeneration.

Low Risk of Serious Complications with Meniscectomy

Lancet reports on the safety of over 1 million arthroscopic partial meniscectomies done in the United Kingdom and found a low overall risk in the first 90 days. They examined Hospital Episode Statistics on  1,088,782 arthroscopic partial meniscectomies (1997-2017); 699 965 of which were eligible for analysis. They sought to identify complications occurring in the 90 days after the index procedure.

Pre-Diabetes Associated Risk for Arthritis, Obesity and Physical Inactivity

The current MMWR reports that arthritis is seen in nearly one-third of adults with prediabetes and that more than half of such patients are obese and not engaged in regular physical activity.

Doctor-diagnosed arthritis affects 54.4 million in the U.S. and the CDC expects this to rise to 78.4 million by 2040.

Controversial New Super Opioid Approved by FDA

Amidst a new DEA report demonstrating a record number of opioid overdose deaths (n-72,000 or ~ 200 deaths per day), the FDA has approved a newer and far more potent opioid than those that are currently being abused at alarming rates. The new agent is named Dsuvia.

Late Breaker: Can Tanezumab Be Revived for OA?

The monoclonal antibody tanezumab, which blocks nerve growth factor, showed significant benefits in pain and function among patients with osteoarthritis (OA) of the knee or hip, and rates of severe adverse joint events such as rapidly progressive OA that had plagued earlier studies were low, a researcher reported at the annual meeting of the American College of Rheumatology in Chicago last week.